Cargando…

Niraparib for ovarian cancer

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671010/
https://www.ncbi.nlm.nih.gov/pubmed/35002037
http://dx.doi.org/10.18773/austprescr.2021.059
_version_ 1784615078276890624
collection PubMed
description
format Online
Article
Text
id pubmed-8671010
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-86710102022-01-06 Niraparib for ovarian cancer Aust Prescr New Drugs NPS MedicineWise 2021-10-27 2021-12 /pmc/articles/PMC8671010/ /pubmed/35002037 http://dx.doi.org/10.18773/austprescr.2021.059 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Niraparib for ovarian cancer
title Niraparib for ovarian cancer
title_full Niraparib for ovarian cancer
title_fullStr Niraparib for ovarian cancer
title_full_unstemmed Niraparib for ovarian cancer
title_short Niraparib for ovarian cancer
title_sort niraparib for ovarian cancer
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671010/
https://www.ncbi.nlm.nih.gov/pubmed/35002037
http://dx.doi.org/10.18773/austprescr.2021.059